$PRCT News

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

William Blair Downgrades PROCEPT BioRobotics to Market Perform

PROCEPT BioRobotics Corporation (PRCT) Q2 2026 Earnings Call Transcript

Procept BioRobotics (NASDAQ:PRCT) Q2 In Line, But Unchanged Guidance Sinks Shares

PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

Procept BioRobotics: Filling Robots Slower Than Placing Them

Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25

Evercore ISI Group Initiates Coverage On PROCEPT BioRobotics with Outperform Rating, Announces Price Target of $30

Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform, Lowers Price Target to $29

PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program

PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch

PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

Procept (PRCT) Q1 2026 Earnings Transcript

Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35

PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary

PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...